O

Ostersjöstiftelsen

Europe, Stockholms Lan, Sweden, Huddinge

Description

Östersjöstiftelsen, an academic investment group, supports research, medical student trainings, and the academic infrastructure in Sweden.

Investor Profile

Ostersjöstiftelsen has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (75%)
  • Seed (13%)
  • Undisclosed (13%)

Country Focus

  • Sweden (100%)

Industry Focus

  • Pharmaceutical
  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Clinical Trials
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ostersjöstiftelsen frequently co-invest with?

Rosetta Capital
Europe, England, United Kingdom, London
Co-Investments: 2
Co-Investments: 1
Sciety
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Karolinska
Europe, Stockholms Lan, Sweden, Solna
Co-Investments: 1
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Midroc New Technology
Europe, Stockholms Lan, Sweden, Solna
Co-Investments: 1
LA
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
P
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2

What are some of recent deals done by Ostersjöstiftelsen?

OncoZenge

Bromma, Sodermanlands Lan, Sweden

OncoZenge develops better products for the supportive care of cancer patients.

BiotechnologyHealth CarePharmaceutical
SeedNov 16, 2020
Amount Raised: $1,160,699
Athera Biotechnologies

Stockholm, Stockholms Lan, Sweden

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

BiotechnologyPharmaceutical
Series UnknownApr 21, 2019
Amount Raised: $5,917,640
Athera Biotechnologies

Stockholm, Stockholms Lan, Sweden

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

BiotechnologyPharmaceutical
Series UnknownAug 29, 2017
Amount Raised: $7,177,178
Modus Therapeutics

Stockholm, Stockholms Lan, Sweden

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series UnknownFeb 20, 2017
Amount Raised: $3,579,963
Dilafor

Solna, Stockholms Lan, Sweden

Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.

BiopharmaPharmaceutical
Series UnknownSep 27, 2016
Amount Raised: $5,941,415
Athera Biotechnologies

Stockholm, Stockholms Lan, Sweden

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

BiotechnologyPharmaceutical
Series UnknownDec 13, 2015
Amount Raised: $2,820,653
DermaGen

Lund, Skane Lan, Sweden

A Valuable contribution to dermatology

BiotechnologyHealth CareTherapeutics
Series UnknownApr 2, 2008
LYYN

Lund, Skane Lan, Sweden

LYYN’s Visibility Enhancement Technology develops image-improving software for subsea, fog, snow, lowlight and medicinal applications.

Software
UndisclosedMay 31, 2007
Amount Raised: $1,012,431